Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson's Disease and "OFF" Episodes

被引：0
|
作者：
Thach, A. [1 ]
Kirson, N. [1 ]
Zichlin, M. [1 ]
Dieye, I. [1 ]
Pappert, E. [1 ]
Williams, G. [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
958
引用
收藏
页码：S427 / S427
页数：1
相关论文
共 50 条
  • [21] Efficacy, Safety, and Tolerability of Supratherapeutic Doses of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients With Parkinson's Disease
    Olanow, C.
    Stocchi, F.
    Wilks, K.
    Peckham, E.
    De Pandis, M.
    Sciarappa, K.
    Kleiman, R.
    Blum, D.
    Navia, B.
    MOVEMENT DISORDERS, 2019, 34
  • [22] Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson's Disease and "OFF" Episodes
    Hui, Jennifer
    Fox, Susan
    Neeson, William
    Bhargava, Parul
    Pappert, Eric
    Blum, David
    Navia, Bradford
    NEUROLOGY, 2020, 94 (15)
  • [23] Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and "OFF" episodes
    Hui, Jennifer S.
    Fox, Susan H.
    Neeson, William
    Bhargava, Parul
    Pappert, Eric
    Blum, David
    Navia, Bradford
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : 110 - 116
  • [24] Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson's Disease and "OFF" Episodes
    Hui, Jennifer
    Fox, Susan
    Neeson, William
    Sciarappa, Kenneth
    Pappert, Eric
    Navia, Bradford
    NEUROLOGY, 2021, 96 (15)
  • [25] A Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease Complicated By "OFF" Episodes
    Stocchi, F.
    Wilks, K. L.
    Peckham, E. L.
    De Pandis, M. F.
    Sciarappa, K.
    Agbo, A.
    Kleiman, R.
    Blum, D.
    Navia, B.
    MOVEMENT DISORDERS, 2019, 34 : S12 - S12
  • [26] Sublingual Apomorphine Manages Parkinson Disease Off Episodes
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (08): : 701 - 701
  • [27] Efficacy of sublingual apomorphine (APL-130277) for the treatment of "off" episodes in patients with Parkinson's disease
    Hauser, R. A.
    Dubow, J.
    Dzyngel, B.
    Bilbault, T.
    Giovinazzo, A.
    Agro, A.
    MOVEMENT DISORDERS, 2015, 30 : S90 - S90
  • [28] Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Hauser, Robert
    Dzyngel, Bruce
    Bilbault, Thierry
    Shill, Holly
    Argo, Albert
    NEUROLOGY, 2016, 86
  • [29] Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Isaacson, Stuart
    Pappert, Eric
    Dzyngel, Bruce
    Bllbault, Thierry
    Argo, Albert
    NEUROLOGY, 2016, 86
  • [30] Safety of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease
    Isaacson, S.
    Dubow, J.
    Dzyngel, B.
    Bilbault, T.
    Giovinazzo, A.
    Agro, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 250 - 250
12345